Cabergoline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Cabergoline.
| Product ID | 50090-3157_0e0b1a1e-5ee5-4fc0-9864-8ab3959e8fd6 |
| NDC | 50090-3157 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cabergoline |
| Generic Name | Cabergoline |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-03-07 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077750 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | CABERGOLINE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Ergolines [CS],Ergot Derivative [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-10-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077750 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-10-06 |
| Marketing End Date | 2019-06-30 |
| Ingredient | Strength |
|---|---|
| CABERGOLINE | .5 mg/1 |
| SPL SET ID: | c9f0b576-d5e5-4e3e-bb5c-3574d75d9907 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-5420 | Cabergoline | Cabergoline |
| 23155-823 | Cabergoline | Cabergoline |
| 49884-673 | Cabergoline | Cabergoline |
| 50090-3157 | Cabergoline | Cabergoline |
| 50090-3951 | Cabergoline | Cabergoline |
| 50090-5834 | Cabergoline | Cabergoline |
| 50742-118 | Cabergoline | Cabergoline |
| 59762-1005 | Cabergoline | cabergoline |
| 68071-4596 | Cabergoline | Cabergoline |
| 70518-2379 | Cabergoline | Cabergoline |